Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients

enthalten in: Transplant Infectious Disease | 2021

von Torabi, J. | Rocca, J. | Ajaimy, M. | +17

Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients

enthalten in: Transplant Infectious Disease | 2021

von Nnani, D. | Campbell, A. | Ajaimy, M. | +5